v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04349618 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
j-christophe.richard@chu-lyon.fr |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-04-16 |
Recruitment status
Last imported at : April 21, 2023, 8 p.m. Source : ClinicalTrials.gov |
Unknown |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
inclusion criteria: - adults aged 18 years or older - ards according to the berlin definition - covid-19 pneumonia confirmed by rt-pcr - acute respiratory failure not fully explained by left ventricular failure or sodium overload - bilateral pulmonary radiological opacities not fully explained by pleural effusions or atelectasis or nodules - invasive mechanical ventilation with pao2/fio2 ≤ 150 mm hg and peep ≥ 5 cm h2o with a tidal volume below or equal to 6 ml per kilogram of predicted body weight - continuous intravenous sedation as part of ards treatment |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
- exclusion criteria related to ards history - ards onset more than 48 hours before inclusion - previous inclusion in present study - exclusion criteria related to ards severity or complications - arterial ph < 7.21 despite respiratory rate set to 35/min at the time of inclusion - patient under any extracorporeal co2 removal technique or ecmo - pneumothorax or bronchopleural fistula - exclusion criteria related to comorbidities - suspected intracranial hypertension - severe chronic obstructive pulmonary disease defined by a gold score ≥ 3 - chronic respiratory failure under home oxygen or non-invasive ventilation - chronic respiratory failure requiring long term oxygen or non-invasive ventilation - obesity with body weight over height ratio greater than 1 kg/cm - sickle cell disease - bone marrow transplant < 6 months - burn injury with extension greater than 30% of body surface area - cirrhosis with child-pugh score c - advance directives to withhold or withdraw life sustaining treatment - exclusion criteria related to legislation - patient under an exclusion period relative to participation to another clinical trial, or inclusion into a clinical trial interfering with the ventilatory strategies - pregnancy, lactating women - patient under a legal protective measure. - lack of affiliation to social security as required by french regulation - lack of written informed consent by patient or next of kin (unless if recourse to the emergency procedure in the absence of a loved one) |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Hospices Civils de Lyon |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
France |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
200 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
A composite score based on all-cause mortality and the number of ventilator free-days (VFD) |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1032, "treatment_name": "Protective ventilation", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1330, "treatment_name": "Ultra protective ventilation", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}] |